Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in healthy volunteers of both sexes
This study was carried out in order to compare the relative bioavailability of two different formulations containing 400 mg of acetaminophen + 4 mg of phenylephrine hydrochloride + 4 mg of chlorpheniramine maleate, Test formulation (Cimegripe®) and Reference formulation (Resfenol®) in 84 healthy vol...
Main Authors: | Alessandra Ferreira dos Santos, Quevellin Alves dos Santos, Carlos Eduardo Melo Correa, Edvaldo Capobiango Coelho |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2020-09-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100564&tlng=en |
Similar Items
-
Simultaneous determination of chlorpheniramine maleate, phenylephrine hydrochloride, paracetamol and caffeine in pharmaceutical preparation by RP-HPLC
by: Redasani V.K., et al.
Published: (2013-01-01) -
Compatibility study of paracetamol, chlorpheniramine maleate and phenylephrine hydrochloride in physical mixtures
by: G.G.G. de Oliveira, et al.
Published: (2017-01-01) -
Chlorpheniramine and phenylephrine induced coronary vasospasm manifesting as Kounis syndrome in a patient with moderate mitral stenosis
by: Altug Osken, et al.
Published: (2016-01-01) -
Quantitative determination of acetaminophen, phenylephrine and carbinoxamine in tablets by high-performance liquid chromatography
by: Carina de A. Bastos, et al.
Published: (2009-01-01) -
RP-HPLC-DAD method for the determination of phenylepherine, paracetamol, caffeine and chlorpheniramine in bulk and marketed formulation
by: A.P. Dewani, et al.
Published: (2014-11-01)